197
Views
7
CrossRef citations to date
0
Altmetric
Original Research

From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB)

, , , , , ORCID Icon, ORCID Icon, , , ORCID Icon, , ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 933-942 | Published online: 24 Dec 2019

References

  • Marinkovich MP. Inherited epidermolysis bullosa In: Wolff K, Johnson R, Saavedra A, Roh E, editors. Fitzpatrick’s Color Atlas and Synopsis of Clinical Dermatology. New York, NY: McGraw-Hill; 2017:649–665.
  • Engel P, Bagal S, Broback M, Boice N. Physician and patient perceptions regarding physician training in rare diseases: the need for stronger educational initiatives for physicians. J Rare Dis. 2013;1(2):1–14.
  • NIH National Center for Advancing Translational Sciences. Genetic and rare disease information center. How to find a disease specialist [Internet]; 2017 [cited 1115, 2019]. Available from: https://rarediseases.info.nih.gov/guides/pages/25/how-to-find-a-disease-specialist. Accessed 1213, 2019.
  • Harvey K, Burke D, Heals S. The evolving role of enzymology and metabolomics in the diagnosis of lysosomal disorders in the post-genomic era. Mol Genet Metab. 2019;126(2):S69. doi:10.1016/j.ymgme.2018.12.164
  • Nakano A, Chao SC, Pulkkinen L, et al. Laminin 5 mutations in junctional epidermolysis bullosa: molecular basis of Herlitz vs non-Herlitz phenotypes. Hum Genet. 2002;110(1):41–51. doi:10.1007/s00439-001-0630-111810295
  • Shinkuma S. Dystrophic Epidermolysis Bullosa: A Review. Vol. 8, Clinical, Cosmetic and Investigational Dermatology. Dove Medical Press Ltd.; 2015:275–284.
  • Solis D, Nazaroff J, Dutt-Singkh Y, et al. Natural history of wounds in recessive dystrophic epidermolysis bullosa. In: 5th World Conference of EB Research & 4th Conference of EB CLINET; 2017; Salzburg, Austria.
  • Saeidian AH, Youssefian L, Moreno Trevino MG, et al. Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico. Clin Exp Dermatol. 2018;43(5):579–584. doi:10.1111/ced.2018.43.issue-529473190
  • van den Akker PC, van Essen AJ, Kraak MMJ, et al. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations. J Dermatol Sci. 2009;56(1):9–18. doi:10.1016/j.jdermsci.2009.06.01519665875
  • Varki R, Sadowski S, Uitto J, Pfendner E. Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes. J Med Genet. 2007;44(3):181–192. doi:10.1136/jmg.2006.04530216971478
  • McKenna KE, Walsh MY, Bingham EA. Epidermolysis bullosa in Northern Ireland. Br J Dermatol. 1992;127(4):318–321. doi:10.1111/bjd.1992.127.issue-41419751
  • van den Akker PC, Jonkman MF, Rengaw T, et al. The international dystrophic epidermolysis bullosa patient registry: an online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations. Hum Mutat. 2011;32(10):1100–1107. doi:10.1002/humu.2155121681854
  • Van Den Akker PC, Mellerio JE, Martinez AE, et al. The inversa type of recessive dystrophic epidermolysis bullosa is caused by specific arginine and glycine substitutions in type VII collagen. J Med Genet. 2011;48(3):160–167. doi:10.1136/jmg.2010.08223021113014
  • Fine JD. Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the national epidermolysis Bullosa registry. JAMA Dermatol. 2016;152(11):1231–1238. doi:10.1001/jamadermatol.2016.247327463098
  • Horn HM, Priestley GC, Eady RAJ, Tidman MJ. The prevalence of epidermolysis bullosa in Scotland. Br J Dermatol. 1997;136(4):560–564. doi:10.1111/j.1365-2133.1997.tb02141.x9155958
  • Pavičić Ž, Kmet‐Vižintin P, Kansky A, Dobrić I. Occurrence of hereditary bullous epidermolyses in croatia. Pediatr Dermatol. 1990;7(2):108–110. doi:10.1111/j.1525-1470.1990.tb00664.x2359725
  • Hernandez-Martín A, Aranegui B, Escámez MJ, et al. Prevalence of dystrophic epidermolysis bullosa in Spain: a population-based study using the 3-source capture-recapture method. Evidence of a need for improvement in care. Actas Dermosifiliogr. 2013;104(10):890–896. doi:10.1016/j.ad.2013.03.00623809583
  • Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. de Brevern AG, editor. PLoS One. 2012;7(10):e46688. doi:10.1371/journal.pone.004668823056405
  • Kircher M, Witten DM, Jain P, O’roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46(3):310–315. doi:10.1038/ng.289224487276
  • Landrum MJ, Lee JM, Benson M, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062–7. doi:10.1093/nar/gkx115329165669
  • Wertheim-Tysarowska K, Sobczyńska-Tomaszewska A, Kowalewski C, et al. The COL7A1 mutation database. Hum Mutat. 2012;33(2):327–331. doi:10.1002/humu.2165122058051
  • Lek M, Karczewski KJ, Minikel EV, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285–291. doi:10.1038/nature1905727535533
  • Shihab HA, Gough J, Cooper DN, et al. Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using Hidden Markov Models. Hum Mutat. 2013;34(1):57–65. doi:10.1002/humu.2222523033316
  • Reva B, Antipin Y, Sander C. Determinants of protein function revealed by combinatorial entropy optimization. Genome Biol. 2007;8(11):R232. doi:10.1186/gb-2007-8-11-r23217976239
  • Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–249. doi:10.1038/nmeth0410-24820354512
  • Ng PC. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31(13):3812–3814. doi:10.1093/nar/gkg50912824425
  • González-Pérez A, López-Bigas N. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am J Hum Genet. 2011;88(4):440–449. doi:10.1016/j.ajhg.2011.03.00421457909
  • Ionita-Laza I, Mccallum K, Xu B, Buxbaum JD. A spectral approach integrating functional genomic annotations for coding and noncoding variants. Nat Genet. 2016;48(2):214–220. doi:10.1038/ng.347726727659
  • Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Drake P. Births: final data for 2016. Natl Vital Stat Rep. 2018;67(1):1–55.
  • Fine J-D. Inherited epidermolysis bullosa. Orphanet J Rare Dis. 2010;5(12):1–17. doi:10.1186/1750-1172-5-1220074341
  • Fine J-D. Epidermolysis Bullosa: Clinical, Epidemiologic, and Laboratory Advances, and the Findings of the National Epidermolysis Bullosa Registry. Johns Hopkins University Press; 1999.
  • Rose S, Van Der Laan MJ. Simple optimal weighting of cases and controls in case-control studies. Int J Biostat. 2008;4:1. doi:10.2202/1557-4679.1115
  • EurostatLive. Live births and crude birth rate [Internet]. [cited 1113, 2019]. Available from: https://ec.europa.eu/eurostat/web/products-datasets/-/tps00204. Accessed 1213, 2019.
  • Binder K, Heermann D, Roelofs L, Mallinckrodt AJ, Mckay S. Monte carlo simulation in statistical physics. Computers in Physics1993;7(2):156–157.
  • Kroese DP, Rubinstein RY. Monte carlo methods. Computational Statistics 2012;4(1):48–58.
  • Watnik M. Early computational statistics. J Comput Graph Stat. 2011;20(4):811–817. doi:10.1198/jcgs.2011.204b
  • Yang CS, Lu Y, Farhi A, et al. An incompletely penetrant novel mutation in COL7A1 causes epidermolysis bullosa pruriginosa and dominant dystrophic epidermolysis bullosa phenotypes in an extended kindred. Pediatr Dermatol. 2012;29(6):725–731. doi:10.1111/pde.2012.29.issue-622515571
  • Fine JD, Bruckner-Tuderman L, Eady RAJ, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol. 2014;70:1103–1126. doi:10.1016/j.jaad.2014.01.903.24690439